- Selective antagonist of mineralocorticoid receptor - new hope for patients with diabetic kidney disease2022 | First Faculty of Medicine
- Should All Patients with Resistant Hypertension Receive Spironolactone?2016 | First Faculty of Medicine, Third Faculty of Medicine
- Prenatal morphine exposure suppresses mineralocorticoid receptor-dependent basal synaptic transmission and synaptic plasticity in the lateral perforant path in adult male rats2003 | Third Faculty of Medicine
- Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes2018 | Third Faculty of Medicine
- London calling ... Impressions and findings from the annual congress of the European Society of Cardiology meeting on the 29th 8 to 2 9th 20152015 | First Faculty of Medicine
- Treatment of resistant hypertension2013 | First Faculty of Medicine
- The importance of pharmacogenetics in the treatment of heart failure2013 | Third Faculty of Medicine
- Finerenone2023 | First Faculty of Medicine
- Current options for slowing the progression of chronic kidney disease2022 | First Faculty of Medicine
- Morphine exposure prevents up-regulation of MR and GR binding sites in the brain of adult male and female rats due to prenatal stress2006 | Third Faculty of Medicine
- Pharmacotherapy in chronic heart failure2015 | First Faculty of Medicine
- Management of resistant hypertension2011 | First Faculty of Medicine
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms2011 | First Faculty of Medicine, Third Faculty of Medicine
- Revival of aldosterone blockers in the treatment of chronic heart failure and results of the EMPHASIS-HF study2011 | First Faculty of Medicine
- New Possibilities in Pharmacotherapy of Chronic Heart Failure2018 | Faculty of Medicine in Hradec Králové
- Oversights and mistakes in heart failure therapy with left ventricular dysfunction2018 | First Faculty of Medicine
- Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension2020 | First Faculty of Medicine
- Antagonists of the renin-angiotensin-aldosterone system2011 | First Faculty of Medicine
- New therapies in transthyretin cardiac amyloidosis2021 | First Faculty of Medicine
- Management of arterial hypertension in patients with chronic heart failure2013 | First Faculty of Medicine
- Treatment of heart failure in diabetic patients2014 | First Faculty of Medicine
- Pharmacological therapy for chronic heart failure2018 | First Faculty of Medicine
- New concept in the treatment of cardiovascular diseases - dual inhibition of neutral endopeptidase and RAA system2017 | First Faculty of Medicine
- Genetic causes of sudden infant death syndrome in the era of next generation sequencing. Review2020 | First Faculty of Medicine, Third Faculty of Medicine
- Expert consensus document from the European Society of Cardiology on catheter-based renal denervation2013 | First Faculty of Medicine, Third Faculty of Medicine
- Geographic variations in the PARADIGM-HF heart failure trial2016 | First Faculty of Medicine
- Dosing of basic pharmacotherapy and its effect on the prognosis of patients hospitalized for heart failure2023 | Faculty of Medicine in Pilsen
- Adherence and blood pressure control in patients with primary aldosteronism2022 | First Faculty of Medicine, Third Faculty of Medicine
- Psychiatrie adverse effects of corticosteroid treatment2018 | Second Faculty of Medicine
- Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial2022 | Publication without faculty affiliation